Idiopathic normal pressure hydrocephalus (iNPH) is a neurologic disorder clinically characterized by gait disturbance, cognitive impairment, and an overactive bladder. Ventriculomegaly has been considered a neuroimaging hallmark of iNPH, which reflects the compression of the brain parenchyma caused by abnormal CSF dynamics. However, differentiating iNPH from neurodegenerative diseases, such as Alzheimer disease and progressive nuclear palsy, is difficult solely based on the existence of ventriculomegaly because this morphologic feature is widely observed in the diseases that cause atrophy of the brain.
In 1998, Kitagaki and colleagues1 first demonstrated that decreased CSF space at the midline high convexity (“high-convexity tightness”) is a distinctive neuroimaging feature of iNPH. Contrary to the widely held view of that time, Sylvian fissure dilation was observed in all patients with iNPH in their patient sample. Following Kitagaki and colleagues’ article, the diagnostic value of these neuroimaging features, which are coined “disproportionately enlarged subarachnoid space hydrocephalus (DESH),” has been confirmed by several multicenter prospective cohort studies.2 To date, a variety of additional neuroimaging features have been proposed for iNPH, including focal enlargement of cortical sulci and bumps in the lateral ventricular roof.
CSF shunt surgery is the criterion standard treatment for iNPH. Unfortunately, the effect of this treatment varies from patient to patient. The presurgical prediction of the effectiveness of shunt surgery is a big issue in the management of iNPH. However, the predictive markers of shunt response are currently poorly defined. To address this issue, we investigated the predictive values of presurgical neuroimaging features, including ventriculomegaly, high-convexity tightness, Sylvian fissure dilation, white matter T2 hyperintensities, focal enlargement of cortical sulci, and bumps in the lateral ventricular roof, for 1-year changes in clinical symptoms after CSF shunt surgery in 60 consecutive patients with iNPH.3